A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects
- 25 February 2000
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 160 (1-2) , 39-49
- https://doi.org/10.1016/s0303-7207(99)00251-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Transcriptional Interferences between Normal or Mutant Androgen Receptors and the Activator Protein 1--Dissection of the Androgen Receptor Functional DomainsEndocrinology, 1999
- Trafficking of Androgen Receptor Mutants Fused to Green Fluorescent Protein: A New Investigation of Partial Androgen Insensitivity SyndromeJournal of Clinical Endocrinology & Metabolism, 1998
- Antiandrogenic effect of RU-486 in the mouse kidneyThe International Journal of Biochemistry & Cell Biology, 1997
- Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogensEndocrinology, 1996
- Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC‐3 prostate cancer cellsThe Prostate, 1995
- Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid [published erratum appears in Endocrinology 1995 May;136(5):2319]Endocrinology, 1995
- Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activationBiochemistry, 1992
- Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptorMolecular and Cellular Endocrinology, 1989